Chitra Lal to Pulmonary Disease, Chronic Obstructive
This is a "connection" page, showing publications Chitra Lal has written about Pulmonary Disease, Chronic Obstructive.
Connection Strength
2.853
-
Emerging Treatments for COPD: Evidence to Date on Revefenacin. COPD. 2020 02; 17(1):112-119.
Score: 0.535
-
Prevalence of self-reported sleep problems amongst adults with obstructive airway disease in the NHANES cohort in the United States. Sleep Breath. 2020 Sep; 24(3):985-993.
Score: 0.526
-
Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD). Expert Opin Pharmacother. 2019 Jun; 20(9):1075-1085.
Score: 0.511
-
A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD. Expert Opin Pharmacother. 2017 Dec; 18(17):1833-1843.
Score: 0.463
-
Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy. Int J Chron Obstruct Pulmon Dis. 2017; 12:135-140.
Score: 0.436
-
Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2015 Feb; 16(3):427-34.
Score: 0.382